Islay Capital Management LLC Purchases 10,004 Shares of Cardinal Health, Inc. (NYSE:CAH)

Islay Capital Management LLC boosted its stake in Cardinal Health, Inc. (NYSE:CAH) by 1,081.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,929 shares of the company’s stock after acquiring an additional 10,004 shares during the period. Islay Capital Management LLC’s holdings in Cardinal Health were worth $1,102,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. Ameriprise Financial Inc. boosted its holdings in shares of Cardinal Health by 82.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company’s stock valued at $358,390,000 after buying an additional 1,862,291 shares in the last quarter. California Public Employees Retirement System boosted its holdings in shares of Cardinal Health by 118.9% during the 4th quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock valued at $152,816,000 after buying an additional 823,520 shares in the last quarter. International Assets Investment Management LLC bought a new stake in shares of Cardinal Health during the 4th quarter valued at $464,800,000. Deutsche Bank AG boosted its holdings in shares of Cardinal Health by 64.9% during the 3rd quarter. Deutsche Bank AG now owns 1,027,670 shares of the company’s stock valued at $89,222,000 after buying an additional 404,609 shares in the last quarter. Finally, Pacer Advisors Inc. boosted its holdings in shares of Cardinal Health by 17.5% during the 4th quarter. Pacer Advisors Inc. now owns 2,619,561 shares of the company’s stock valued at $264,052,000 after buying an additional 389,431 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.2 %

Cardinal Health stock traded down $0.19 during midday trading on Tuesday, hitting $102.72. The stock had a trading volume of 743,457 shares, compared to its average volume of 2,230,052. The firm’s fifty day moving average is $109.48 and its two-hundred day moving average is $104.93. The company has a market capitalization of $24.98 billion, a PE ratio of 40.46, a P/E/G ratio of 1.04 and a beta of 0.68. Cardinal Health, Inc. has a 52-week low of $77.56 and a 52-week high of $116.04.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.56 by $0.26. The company had revenue of $57.45 billion during the quarter, compared to analyst estimates of $57.02 billion. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.32 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 7.28 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were issued a dividend of $0.5006 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio (DPR) is currently 78.74%.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of research reports. Argus upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating in a report on Friday, February 9th. Barclays began coverage on shares of Cardinal Health in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price target on the stock. Wells Fargo & Company dropped their price target on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating on the stock in a research note on Monday. SVB Leerink initiated coverage on shares of Cardinal Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $125.00 price target on the stock. Finally, StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, April 24th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $102.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.